SEC Form D · filed November 3, 2021
Cardurion Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
Amy Schulman · Boston, MADirectorJeb Keiper · Boston, MADirectorMichael Mendelsohn · Boston, MAExec · DirectorKenneth Novack · Boston, MADirectorKeith Gottesdiener · Boston, MADirectorPeter Lawrence · Boston, MAExec · DirectorNicholas Downing · Boston, MADirectorJustin M. Scott · Mt. Pleasant, SCExec · DirectorChristopher N. Crow · Wilsonville, ORDirectorDain N. Zaitz · Wilsonville, ORDirectorRobert D. Milks, Jr · Grayson, GADirectorAdam Koppel · Boston, MADirectorConstantine H. Iordanou · Hamilton, BermudaDirectorBrian H. Schreiber · Washington, Washington, D.C.DirectorDalton M. Dale · ST. PETERSBURG, FLDirectorDesmond E. Mitchell · Luxembourg, LuxembourgExec · DirectorKeith Gottesdiener · Boston, MADirectorAdam Koppel · Cambridge, MADirectorPeter Lawrence · Boston, MAExec · DirectorNicholas Downing · Boston, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗